Atlas Trials

Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer

Clinical trial NCT07371910 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07371910
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Breast CancerHRD-Positive/HER2-Negative Advanced Breast Cancer
Start date
2024-06-12
Primary completion
2031-03-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.